Nine-year Follow-Up of Lenalidomide Plus Rituximab As Initial Treatment for Mantle Cell Lymphoma.
Blood Advances(2023)
关键词
Mantle Cell Lymphoma,Rituximab,Post-Transplant Lymphoproliferative Disease,Lymphoma
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要